Alpa Laboratories Ltd ALPA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹56.58
- Day Range
- ₹56.57–57.95
- 52-Week Range
- ₹46.10–92.50
- Bid/Ask
- ₹56.85 / ₹57.74
- Shares Outstanding
- 21.04M
- Market Cap
- ₹1.21B
- Volume/Avg
- 7,290 / 16,230
Key Statistics
- Price/Earnings (Normalized)
- 33.68
- Price/Sales
- 1.06
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Alpa Laboratories Ltd is a WHO-GMP and ISO-certified pharmaceutical formulations manufacturer engaged in the development, manufacture, and marketing of a diversified portfolio of Finished Dosage Forms (FDFs) spanning ethical, generic, and over-the-counter (OTC) formulations. The Company is engaged in the manufacturing and marketing of pharmaceutical products, with its business comprising the manufacture and sale of Drugs and Chemicals. The Company manufactures a wide range of ethical, generic, and OTC medicines under its own brands as well as for several reputed Indian and multinational pharmaceutical companies through contract manufacturing partnerships. Its product portfolio includes tablets, capsules, injections, syrups, ointments, creams, and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 457
- Website
- https://www.alpalabs.in
Valuation
Metric | ALPA |
|---|---|
Price/Earnings (Normalized) | 33.68 |
Price/Book Value | 0.64 |
Price/Sales | 1.06 |
Price/Cash Flow | 71.10 |
Price/Earnings
ALPA
Financial Strength
Metric | ALPA |
|---|---|
Quick Ratio | 3.53 |
Current Ratio | 4.01 |
Interest Coverage | 19.43 |
Quick Ratio
ALPA
Profitability
Metric | ALPA |
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ALPA
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|?@L<%&F | LOCK|^lc$ | $73B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|W?sl%ztJ | LOCK|@$jkp | $50B | |||
| Haleon PLC ADR HLN | LOCK|yV!x&FL | LOCK|&& | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|<C%?Zww | LOCK|!Ww | $34B | |||
| Viatris Inc VTRS | LOCK|YsHFj&d | LOCK|p# | $24B | |||
| Elanco Animal Health Inc ELAN | LOCK|&@r | LOCK|kk | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|l&yNPL | LOCK|<vZ | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|?x#c<q# | LOCK|SxY | $4B | |||
| Perrigo Co PLC PRGO | LOCK|fdH&zm | LOCK|gF> | $2B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|dPWySM | LOCK|@bgwl | $2B |
United States